Solutions Products Resources Support About Us Contact GLOBAL (ENGLISH) About VASCO Press Overview | VASCO Data Security Share Linkedin Facebook Twitter Email VASCO MYDIGIPASS Gains SAFE-BIOPHARMA Full-Service Credential Service Provider Certification OAKBROOK TERRACE, IL and TENAFLY, NJ – August 10, 2016 -- VASCO Data Security International, Inc. (NASDAQ: VDSI), a global leader in digital solutions including identity, security and business productivity, announced today that it has become a certified full-service Credential Service Provider in the SAFE-BioPharma Trust Framework, a unit of the global SAFE-BioPharma™ IT security standard used in the life sciences. The company has certified its MYDIGIPASS™ identity proofing, multifactor authentication, and federation service to be compliant with the global SAFE-BioPharma digital identity standard. MYDIGIPASS enables application providers to deliver a simple, single, and secure login experience for their users across multiple web and mobile applications. MYDIGIPASS was certified at NIST Level of Authentication (LOA) 3. LOA 3 is considered the minimum level of assurance required to authenticate end users in most transactions with regulated industries such as pharmaceuticals and health care. Authentication is the process that proves the user's identity to online systems and applications. VASCO’s multifactor authentication service proves an individual's cyber identity with greater certainty. The factors may be something the user has (e.g., a cell phone to which a one time password may be sent), something the user knows (e.g., a username), or something the user is (e.g., fingerprint, iris scan, or other biometric). Two-factor authentication is required for compliance with the SAFE-BioPharma standard at LOA 3. "VASCO secures access to health care applications used by clinicians and patients. Our certification under the SAFE-BioPharma Trust Framework means our non-PKI LOA 3 credentials meet Federal Identity, Credential, and Access Management (FICAM) requirements,” stated Frederik Mennes, Senior Manager Market & Security Strategy for VASCO Data Security. “This brings trust to health care organizations looking for strong identity proofing and multifactor authentication services.” "Certification of MYDIGIPASS provides the biopharmaceutical and health care marketplaces with confidence that the service is part of the growing and trusted ecosystem of products and services compliant with the SAFE-BioPharma standard," explains Dr. Peter Alterman, Chief Operating Officer, SAFE-BioPharma Association. SAFE-BioPharma Association was developed by leaders in the biopharmaceutical industry to assure that digital identities can be trusted and to allow for the use of digital signatures on electronic regulatory forms and other documents. Individuals qualifying for a SAFE-BioPharma compliant identity credential can use it to replace all other cyber identities with any company which is a member of SAFE-BioPharma Association or with any other entities with which SAFE-BioPharma has negotiated acceptance, including all US Federal agencies. About SAFE-BioPharma More information on the SAFE-BioPharma® standard for digital identity and digital signatures used in life science and health care settings on the SAFE-BioPharma website. SAFE-BioPharma® is a trademark of SAFE-BioPharma Association. Use of this trademark requires approval from SAFE-BioPharma Association. About VASCO VASCO is a global leader in delivering trust and business productivity solutions to the digital market. VASCO develops next generation technologies that enable more than 10,000 customers in 100 countries in financial, enterprise, government, healthcare and other segments to achieve their digital agenda, deliver an enhanced customer experience and meet regulatory requirements. More than half of the top 100 global banks rely on VASCO solutions to protect their online, mobile, and ATM channels. VASCO’s solutions combine to form a powerful trust platform that empower businesses by incorporating identity, fraud prevention, electronic signatures, mobile application protection and risk analysis. Learn more about VASCO at VASCO.com and on Twitter, LinkedIn and Facebook. Copyright © 2016 VASCO Data Security, Inc., VASCO Data Security International GmbH. All rights reserved. VASCO® and MYDIGIPASS™ are registered or unregistered trademarks of VASCO Data Security, Inc. and/or VASCO Data Security International GmbH in the U.S. and other countries. VASCO Data Security Contact: Corporate Communications: +1-847-370-1486 (US) or +32 2 609 97 00 (ROW) pr@vasco.com SAFE-BioPharma Contact: Jon Weisberg: +1-801-860-9977 jweisberg@safe-biopharma.org Industries Banking & Financial Services Healthcare Government e-Gaming Payments Initiatives Mobile App Security Compliance Fraud Prevention Identity & Access Transaction Signing Document eSignatures Two-Factor Authentication About VASCO Company Overview Press Leadership Careers Investors Offices Partners Where to Buy Technology Partners Channel Partners Become a Channel Partner Visit Our Partner Portal plus youtube facebook twitter linkedin blog vimeo Privacy Statement Terms of Use Cookie Policy Sitemap © 2016 VASCO Data Security International, Inc. All rights reserved. ✖ If you continue browsing the site, you consent to the use of cookies on this website. Note that you can change your browser/cookie settings at any time. To learn more about the use of cookies and how to adjust your settings, please read our cookie policy. Need Help?